PL1896502T3 - Leczenie infekcji grzybowych i/lub protista - Google Patents
Leczenie infekcji grzybowych i/lub protistaInfo
- Publication number
- PL1896502T3 PL1896502T3 PL06755636T PL06755636T PL1896502T3 PL 1896502 T3 PL1896502 T3 PL 1896502T3 PL 06755636 T PL06755636 T PL 06755636T PL 06755636 T PL06755636 T PL 06755636T PL 1896502 T3 PL1896502 T3 PL 1896502T3
- Authority
- PL
- Poland
- Prior art keywords
- fungal
- treatment
- protist infections
- protist
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N37/30—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the groups —CO—N< and, both being directly attached by their carbon atoms to the same carbon skeleton, e.g. H2N—NH—CO—C6H4—COOCH3; Thio-analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0513096.8A GB0513096D0 (en) | 2005-06-28 | 2005-06-28 | Treatment of microbial infections |
EP06755636.5A EP1896502B1 (en) | 2005-06-28 | 2006-06-26 | Treatment of fungal and/or protist infections |
PCT/GB2006/002350 WO2007000584A1 (en) | 2005-06-28 | 2006-06-26 | Treatment of fungal and/or protist infections |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1896502T3 true PL1896502T3 (pl) | 2013-12-31 |
Family
ID=34856225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06755636T PL1896502T3 (pl) | 2005-06-28 | 2006-06-26 | Leczenie infekcji grzybowych i/lub protista |
Country Status (15)
Country | Link |
---|---|
US (3) | US20080207508A1 (pl) |
EP (1) | EP1896502B1 (pl) |
JP (1) | JP2008546831A (pl) |
KR (2) | KR20110099069A (pl) |
CN (1) | CN101208355A (pl) |
AU (1) | AU2006263600B2 (pl) |
BR (1) | BRPI0612103A2 (pl) |
CA (1) | CA2610720A1 (pl) |
DK (1) | DK1896502T3 (pl) |
ES (1) | ES2427171T3 (pl) |
GB (1) | GB0513096D0 (pl) |
HK (1) | HK1113162A1 (pl) |
PL (1) | PL1896502T3 (pl) |
RU (1) | RU2008102928A (pl) |
WO (1) | WO2007000584A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0329958D0 (en) | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
GB0513096D0 (en) | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
ITTO20080894A1 (it) * | 2008-12-02 | 2010-06-03 | Bioindustry Park Del Canavese S P A | Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso |
JP5463515B2 (ja) * | 2009-02-12 | 2014-04-09 | 独立行政法人農業生物資源研究所 | 抗微生物ペプチドを固定化した素材 |
JP6495821B2 (ja) * | 2012-09-07 | 2019-04-03 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | ペプチドおよびそれらの使用 |
WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
LT3237436T (lt) | 2014-12-24 | 2019-09-25 | Aadigen, Llc | Peptidai ir nanodalelės, skirti molekulių įvedimui į ląstelę |
AU2015396744B2 (en) * | 2015-05-29 | 2020-04-16 | Hexima Limited | A method of in vivo treatment |
CN105749250A (zh) * | 2016-03-14 | 2016-07-13 | 吉林大学 | 林蛙抗菌肽在治疗灰指甲的药物制备中的用途 |
CN116376795B (zh) * | 2023-03-29 | 2023-11-07 | 中国水产科学研究院珠江水产研究所 | 一种表达hsp70的重组乳酸菌及其制备方法与应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
GB9705831D0 (en) | 1997-03-20 | 1997-05-07 | Univ Leicester | Oxidised ldl |
KR100314721B1 (ko) | 1998-01-22 | 2001-11-23 | 김일웅 | 생물학적 활성이 있는 신규한 펩타이드 |
WO1999045950A2 (en) | 1998-03-11 | 1999-09-16 | Duke University | Methods of suppressing microglial activation |
US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
US6664230B1 (en) | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
GB0103424D0 (en) | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
US20040014955A1 (en) | 2001-12-17 | 2004-01-22 | Carlos Zamudio | Identification of essential genes of cryptococcus neoformans and methods of use |
US20050058689A1 (en) * | 2003-07-03 | 2005-03-17 | Reactive Surfaces, Ltd. | Antifungal paints and coatings |
US20050208078A1 (en) * | 2003-11-20 | 2005-09-22 | Hoffman Stephen L | Methods for the prevention of malaria |
WO2005039534A1 (en) | 2003-10-01 | 2005-05-06 | Children's Hospital & Research Center At Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
GB0329254D0 (en) | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
ITFI20030324A1 (it) | 2003-12-22 | 2005-06-23 | Celbo S R L | Gruppo guidafilo per distribuire ed avvolgere filati per formare bobine. |
GB0329958D0 (en) * | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
GB0513096D0 (en) | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
-
2005
- 2005-06-28 GB GBGB0513096.8A patent/GB0513096D0/en not_active Ceased
-
2006
- 2006-06-26 ES ES06755636T patent/ES2427171T3/es active Active
- 2006-06-26 CA CA002610720A patent/CA2610720A1/en not_active Abandoned
- 2006-06-26 KR KR1020117019503A patent/KR20110099069A/ko not_active Application Discontinuation
- 2006-06-26 US US11/916,627 patent/US20080207508A1/en not_active Abandoned
- 2006-06-26 JP JP2008518952A patent/JP2008546831A/ja active Pending
- 2006-06-26 BR BRPI0612103-9A patent/BRPI0612103A2/pt not_active IP Right Cessation
- 2006-06-26 KR KR1020087002160A patent/KR20080030060A/ko not_active Application Discontinuation
- 2006-06-26 AU AU2006263600A patent/AU2006263600B2/en not_active Ceased
- 2006-06-26 EP EP06755636.5A patent/EP1896502B1/en not_active Not-in-force
- 2006-06-26 WO PCT/GB2006/002350 patent/WO2007000584A1/en active Application Filing
- 2006-06-26 PL PL06755636T patent/PL1896502T3/pl unknown
- 2006-06-26 DK DK06755636.5T patent/DK1896502T3/da active
- 2006-06-26 CN CNA200680023372XA patent/CN101208355A/zh active Pending
- 2006-06-26 RU RU2008102928/13A patent/RU2008102928A/ru not_active Application Discontinuation
-
2008
- 2008-08-08 HK HK08108780.9A patent/HK1113162A1/xx not_active IP Right Cessation
-
2011
- 2011-12-22 US US13/335,549 patent/US8916516B2/en not_active Expired - Fee Related
-
2014
- 2014-11-14 US US14/542,319 patent/US20150190462A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006263600B2 (en) | 2012-09-20 |
DK1896502T3 (da) | 2013-10-14 |
US20120258907A1 (en) | 2012-10-11 |
WO2007000584A1 (en) | 2007-01-04 |
HK1113162A1 (en) | 2008-10-24 |
WO2007000584A8 (en) | 2013-01-24 |
US8916516B2 (en) | 2014-12-23 |
EP1896502B1 (en) | 2013-07-31 |
US20080207508A1 (en) | 2008-08-28 |
CA2610720A1 (en) | 2007-01-04 |
JP2008546831A (ja) | 2008-12-25 |
EP1896502A1 (en) | 2008-03-12 |
BRPI0612103A2 (pt) | 2011-12-20 |
CN101208355A (zh) | 2008-06-25 |
GB0513096D0 (en) | 2005-08-03 |
ES2427171T3 (es) | 2013-10-29 |
US20150190462A1 (en) | 2015-07-09 |
KR20080030060A (ko) | 2008-04-03 |
KR20110099069A (ko) | 2011-09-05 |
RU2008102928A (ru) | 2009-08-10 |
AU2006263600A1 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257622B (en) | Methods and preparations for the treatment of persistent infections | |
PL1896502T3 (pl) | Leczenie infekcji grzybowych i/lub protista | |
CR9878A (es) | Tratamiento y profilaxis de microangiopatias | |
IL228770A0 (en) | processes and intermediates | |
EP1968649A4 (en) | NANOPARTICLES OF PROTEINS AND THEIR USE | |
HK1134679A1 (zh) | 用於治療感染的組合物和方法 | |
HK1120160A1 (en) | Trenched-gate field effect transistors and methods of forming the same | |
EP1838331A4 (en) | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | |
IL179873A0 (en) | Methods of treatment of endobronchial infections | |
HK1144373A1 (en) | Use of fungal immunomodulatory protein | |
DE602006008481D1 (de) | Rauschunterdrückungsverfahren und -vorrichtungen | |
EP1978099A4 (en) | ANTIBACTERIAL SUBSTANCE DM0507 AND ITS USE | |
EP1889058A4 (en) | DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS | |
IL190969A0 (en) | Pyrazoles useful in the treatment of inflammation | |
IL189252A0 (en) | Dihydroxyanthraquinones and their use | |
IL187405A0 (en) | Methods and compositions for the treatment of pain | |
ZA200709024B (en) | Method of well treatment and construction | |
EP1859826A4 (en) | CONTRAST REMOVAL SYSTEM AND METHOD FOR ACTIVATING THE CONTRAST REMOVAL SYSTEM | |
EP1951282A4 (en) | TREATMENT OF HYPERSENSITIVITY | |
GB0504657D0 (en) | Compositions and methods of treatment | |
LT1951374T (lt) | Dantenų kišenių infekcijų gydymas | |
EP1978999A4 (en) | ISOLATED MCPIP PROTEIN AND METHODS OF USE | |
ZA200710476B (en) | Methods and compositions for the treatment of pain | |
GB0408521D0 (en) | Treatment of sepsis | |
EP1956029A4 (en) | FACTOR FOR THE PREDICTION OF VASCULAR AGING AND THE APPLICATION THEREOF |